| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |